发明名称 |
Tetrapeptide regulating blood glucose level in diabetes mellitus |
摘要 |
The invention refers to the field of medicine and can be applied as a substance capable of regulating glucose level while treating and preventing diabetes mellitus. There is proposed a biologically active new tetrapeptide lysyl-glutamyl-aspartyl-tryp-tophane of general formula Lys-Glu-Asp-Trp-NH<SUB>2 </SUB>capable of regulating the glucose level, and pharmacological substance containing an effective amount of tetrapeptide lysyl-glutamyl-aspartyl-tryptophane of the general formula Lys-Glu-Asp-Trp-NH<SUB>2</SUB>. There is proposed the method of prevention and/or treatment of the diabetes mellitus, which consists in administering to a patient of the pharmacological substance, containing as an active peptide agent an effective amount of Lys-Glu-Asp-Trp-NH<SUB>2 </SUB>tetrapeptide in doses of 0.1-30 mug/kg of the body weight at least once a day for a period necessary for attaining a therapeutic effect.
|
申请公布号 |
US2007142298(A1) |
申请公布日期 |
2007.06.21 |
申请号 |
US20040580957 |
申请日期 |
2004.08.09 |
申请人 |
SANKT-PETERBURGSKAYA OBSCHESTVENNAYA ORGANIZATSIYA "SANKT-PETERBURGSKIY INSTITUT BIOREG |
发明人 |
KHAVINSON VLADIMIR K.;MALININ VLADIMIR V.;RYZHAK GALINA A.;GRIGORIEV EVGENY I. |
分类号 |
A61K38/06;A61K38/07;A61K38/00;A61P3/10;C07K5/10;C07K5/11 |
主分类号 |
A61K38/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|